Abstract
Background: Some studies demonstrated that under high-glucose (HG) condition, osteoblasts develop oxidative stress, which will impair their normal functions. The effects of activin receptor-like kinase 7 (ALK7) silencing on HG-induced osteoblasts remained unclear.
Objective: The aim of this study was to explore the effect of ALK7 on HG-induced osteoblasts.
Methods: MC3T3-E1 cells were treated with different concentrations of HG (0, 50, 100, 200 and 300mg/dL), and the cell viability was detected using cell counting kit-8 (CCK-8). HG-treated MC3T3-E1 cells were transfected with siALK7 or ALK7 overexpression plasmid or siNrf2, and then the viability and apoptosis were detected by CCK-8 and flow cytometry. The levels of Reactive Oxygen Species (ROS), collagen I and calcification nodule were determined by oxidative stress kits, Enzyme-linked immunosorbent assay and Alizarin red staining. The expressions of NF-E2-related factor 2 (Nrf2), heme oxygenase-1 (HO-1) and osteoblast-associated genes were determined by quantitative real-time PCR (qRT-PCR) and Western blot.
Results: Cell viability was reduced with HG treatment. Silencing ALK7 inhibited the effect of HG on increasing cell apoptosis and ROS production, reduced cell viability, mineralized nodules, and downregulated collagen I and osteoblast-associated genes expression in MC3T3-E1 cells. ALK7 silencing activated the Nrf2/HO-1 signaling pathway by affecting expressions of HO-1 and Nrf2. ALK7 overexpression had the opposite effects. In addition, siNrf2 partially reversed the effects of ALK7 silencing on HG-induced MC3T3-E1 cells.
Conclusion: ALK7 silencing protected osteoblasts under HG condition possibly through activating the Nrf2/HO-1 pathway.
Keywords: ALK7, osteoblasts, high glucose, reactive oxygen species, Nrf2/HO-1 signaling pathway, diabetic osteoporosis.
[http://dx.doi.org/10.1007/s00223-016-0177-8] [PMID: 27461216]
[http://dx.doi.org/10.1016/j.ecl.2013.09.004] [PMID: 24582100]
[http://dx.doi.org/10.1359/jbmr.070510]
[http://dx.doi.org/10.7861/clinmedicine.14-2-187] [PMID: 24715132]
[PMID: 17572649]
[http://dx.doi.org/10.1016/j.mce.2016.03.036] [PMID: 27068641]
[http://dx.doi.org/10.1007/s10541-005-0102-7] [PMID: 15807660]
[http://dx.doi.org/10.1002/ptr.6668] [PMID: 32155298]
[http://dx.doi.org/10.2152/jmi.53.238] [PMID: 16953060]
[http://dx.doi.org/10.1007/s10528-012-9555-8] [PMID: 23264230]
[http://dx.doi.org/10.1073/pnas.0801285105] [PMID: 18480258]
[http://dx.doi.org/10.1128/MCB.24.21.9383-9389.2004] [PMID: 15485907]
[http://dx.doi.org/10.2337/db17-1201] [PMID: 29945891]
[http://dx.doi.org/10.2337/db12-0295] [PMID: 22933117]
[http://dx.doi.org/10.1016/j.biocel.2013.06.018] [PMID: 23830891]
[http://dx.doi.org/10.1016/j.devcel.2019.04.015] [PMID: 31063757]
[http://dx.doi.org/10.1007/s00592-014-0706-8] [PMID: 25577243]
[http://dx.doi.org/10.1111/1440-1681.13189] [PMID: 31608496]
[http://dx.doi.org/10.1006/meth.2001.1262] [PMID: 11846609]
[http://dx.doi.org/10.1155/2019/1041583] [PMID: 31781320]
[http://dx.doi.org/10.3390/molecules23092306] [PMID: 30201908]
[http://dx.doi.org/10.1093/bib/bbs075] [PMID: 23175680]
[http://dx.doi.org/10.1080/15476278.2019.1633869] [PMID: 31272281]
[http://dx.doi.org/10.2174/1574888X10666151001114527] [PMID: 26423300]
[http://dx.doi.org/10.1002/jcb.25126] [PMID: 25704854]
[http://dx.doi.org/10.1080/21691401.2019.1591428] [PMID: 30942633]
[http://dx.doi.org/10.3892/mmr.2019.10552] [PMID: 31432111]
[http://dx.doi.org/10.1038/nrendo.2016.12] [PMID: 26893264]
[http://dx.doi.org/10.4103/1735-5362.228954] [PMID: 29853933]
[http://dx.doi.org/10.1038/srep41094] [PMID: 28112219]
[http://dx.doi.org/10.1111/iej.12876] [PMID: 29143348]
[http://dx.doi.org/10.2174/1566524019666191016150757] [PMID: 31622191]
[http://dx.doi.org/10.1016/j.ejphar.2020.173038] [PMID: 32105681]
[http://dx.doi.org/10.1530/ERC-18-0082] [PMID: 30012586]
[http://dx.doi.org/10.1042/bj3330291]
[http://dx.doi.org/10.1126/sciadv.aav6789] [PMID: 31489365]